Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer

作者: Ryan A Hutchinson , Richard A Adams , Darragh G McArt , Manuel Salto-Tellez , Bharat Jasani

DOI: 10.1186/S12967-015-0531-Z

关键词:

摘要: The treatment of cancer is becoming more precise, targeting specific oncogenic drivers with targeted molecular therapies. epidermal growth factor receptor has been found to be over-expressed in a multitude solid tumours. Immunohistochemistry widely used the fields diagnostic and personalised medicine localise visualise disease proteins. To date clinical utility immunohistochemistry determining monoclonal antibody efficacy remained somewhat inconclusive. lack an agreed reproducible scoring criteria for has, various trials yielded conflicting results as use assay companion diagnostic. This resulted this test being removed from licence drug panitumumab not performed practice cetuximab. In review we explore reasons behind particular emphasis on colorectal cancer, suggest way resolving situation through improving precision quantitative image analysis digitised images complemented morphological techniques such situ hybridisation section based gene mutation analysis.

参考文章(153)
Brandon D Gallas, Aldo Badano, Stephen M Hewitt, Marios A Gavrielides, Petra Lenz, Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy. Archives of Pathology & Laboratory Medicine. ,vol. 135, pp. 233- 242 ,(2011) , 10.1043/1543-2165-135.2.233
Barbara L Parsons, Meagan B Myers, Personalized cancer treatment and the myth of KRAS wild-type colon tumors Discovery Medicine. ,vol. 15, pp. 259- 267 ,(2013)
Lance A. Liotta, Elise C. Kohn, The microenvironment of the tumour-host interface Nature. ,vol. 411, pp. 375- 379 ,(2001) , 10.1038/35077241
James W. Mandell, Phosphorylation State-Specific Antibodies : Applications in Investigative and Diagnostic Pathology American Journal of Pathology. ,vol. 163, pp. 1687- 1698 ,(2003) , 10.1016/S0002-9440(10)63525-0
Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, Helen K Angell, Anne Berger, Christine Lagorce, Alessandro Lugli, Inti Zlobec, Arndt Hartmann, Carlo Bifulco, Iris D Nagtegaal, Richard Palmqvist, Giuseppe V Masucci, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Michele Maio, Luigi Laghi, Fabio Grizzi, Martin Asslaber, Corrado D'Arrigo, Fernando Vidal‐Vanaclocha, Eva Zavadova, Lotfi Chouchane, Pamela S Ohashi, Sara Hafezi‐Bakhtiari, Bradly G Wouters, Michael Roehrl, Linh Nguyen, Yutaka Kawakami, Shoichi Hazama, Kiyotaka Okuno, Shuji Ogino, Peter Gibbs, Paul Waring, Noriyuki Sato, Toshihiko Torigoe, Kyogo Itoh, Prabhu S Patel, Shilin N Shukla, Yili Wang, Scott Kopetz, Frank A Sinicrope, Viorel Scripcariu, Paolo A Ascierto, Francesco M Marincola, Bernard A Fox, Franck Pagès, None, Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. The Journal of Pathology. ,vol. 232, pp. 199- 209 ,(2014) , 10.1002/PATH.4287
Hege G. Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale, Insight into the heterogeneity of breast cancer through next-generation sequencing Journal of Clinical Investigation. ,vol. 121, pp. 3810- 3818 ,(2011) , 10.1172/JCI57088
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073
Samy Lamouille, Jian Xu, Rik Derynck, Molecular mechanisms of epithelial–mesenchymal transition Nature Reviews Molecular Cell Biology. ,vol. 15, pp. 178- 196 ,(2014) , 10.1038/NRM3758